Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01068210 · ClinicalTrials.gov registry record · NA

Lung Cancer Exercise Training Study

A NA study, sponsored by Memorial Sloan Kettering Cancer Center.

Completed
Registry status
NA
Development phase
110
Enrollment target

NCT01068210: Completed NA study, sponsored by Memorial Sloan Kettering Cancer Center.

NCT01068210 is a NA study that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 110 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT01068210, a NA study, has completed, sponsored by Memorial Sloan Kettering Cancer Center.

COMPLETED
Registry status
NA
Development phase
110 participants
Enrollment target

Study Summary

The purpose of the study is look at the effects of different types of exercise training with a stretching group and its effect on lung cancer patients. Subjects will take part in a 16 week training intervention that can consist of aerobic, resistance, aerobic \& resistance, or a control group. Pre and Post testing will include stress tests, echos, blood, and urine samples.

Primary Outcome

To compare the efficacy of different types of exercise training modalities, relative to progressive stretching (attention control group)

Interventions

  • BEHAVIORAL Resistance Training
  • BEHAVIORAL Aerobic Training
  • BEHAVIORAL Progressive Stretching
  • BEHAVIORAL Aerobic and Resistance Training

Trial Details

FieldValue
Enrollment Target 110 participants
Start Date 2015-10
Est. Completion 2024-03-29
Phase NA
Memorial Sloan Kettering Cancer Center

1,884 total trials

What the finished NCT01068210 record still lists

NCT01068210 is an interventional study that assigns participants to a tested intervention. The registered 110 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).

The record links to 0 conditions, and to 4 interventions - of which Resistance Training is the first listed.

NCT01068210 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01068210 about?

NCT01068210 is a clinical study titled "Lung Cancer Exercise Training Study". The purpose of the study is look at the effects of different types of exercise training with a stretching group and its effect on lung cancer patients. Subjects will take part in a 16 week training intervention that can consist of aerobic, resistance, aerobic \& resistance, or a control group. Pre a...

What is the current status of trial NCT01068210?

This trial is currently completed. It is a NA study. The enrollment target is 110 participants. The study started on 2015-10. Estimated completion is 2024-03-29.

What interventions are being tested in trial NCT01068210?

The interventions under investigation include: Resistance Training (BEHAVIORAL), Aerobic Training (BEHAVIORAL), Progressive Stretching (BEHAVIORAL), Aerobic and Resistance Training (BEHAVIORAL).

Who is sponsoring clinical trial NCT01068210?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01068210's enrollment target sits among peer trials

110 816th of 2000 higher than 1,176 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01530373 · 110 participants · Phase 2

    Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients

  • NCT02379377 · 110 participants · Phase 1

    18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant

  • NCT02411773 · 110 participants · Phase 1

    Sympatholysis in Chronic Kidney Disease

  • NCT03190941 · 110 participants · Phase 1

    Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01068210, the US trial registry maintained by the National Library of Medicine. NCT01068210 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.